Skip to main content

TERUMO GLOBAL

Search

Select Region

Show — Select Region Hide — Select Region

- Regions/Countries
  - - Europe
    - Latin America
      - Mexico
        
        Brazil
        
        Colombia
        
        Chile and Argentina
        
        Latin America
  - - Asia Pacific
    - Australia
    - Korea
    - Vietnam
    - China
    - India
- Global Business website

About Terumo
About Terumo
Dear Stakeholders
Terumo Group Identity
Terumo Group Code of Conduct
Corporate Profile
Corporate Governance
Compliance
Procurement Activity
Regulations and Standards
Directors and Executive Officers
History
Our Stories
Terumo's Response to COVID-19
Business Overview
Business Overview
TIS Division (Terumo Interventional Systems)
Neurovascular Division (MicroVention)
Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division
Vascular Graft Division (Terumo Aortic)
Hospital Care Solutions Division / Life Care Solutions Division
Pharmaceutical Solutions Division
Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies)
Sustainability
Sustainability
Sustainability News
Message from Top Management
Sustainability at the Terumo Group
Resolving Healthcare Challenges
Creating a Diverse and Inclusive Workplace
Reducing Environmental Footprint
Serving Our Communities
Report Library
GRI Standards Index
Technology
Technology
Basic Information
Basic Information Top
Research and Development
Production and Supply
Intellectual Property
Terumo Fellows
Stories - Our Technologies
Investors
Investors
Management Policy
Management Policy
Top Management Message
Business Risks
Disclaimer
IR Policy
Financial Highlights
IR Library
IR Library
Financial Statements
Presentations
Consolidated Financial Statements
Terumo Reports
IR Events
Shareholders & Stock
Shareholders Meeting
Stock Information
Shareholder Return
Credit Ratings and Corporate Bond
Analyst Coverage
Articles of Incorporation
Site Quote
IR Inquiries
News
News
May 25, 2022
Corporate
Terumo Blood and Cell Technologies Inaugurates Second Manufacturing Facility in Colorado
May 17, 2022
Corporate
Terumo Pharmaceutical Solutions Offers Pre-Fillable Syringe Solutions for Demanding Low Dose Applications Such as Ophthalmic
May 16, 2022
Corporate
Terumo Announces Change in Indication for Dexcom G6 CGM System in Japan
Adjunctive use of Blood Glucose Meter Principally Not Required
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Global Network
Global Network
Japan
North America
South America
Europe, Middle East and Africa
Greater China
Asia and Pacific

Breadcrumb

Home
News

News

Move to top

Top

Refining Searches

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

Corporate

Financial

December 25, 2014

Corporate

Terumo Commences Sales of Tercross® PTA Balloon Catheters in Europe

Designed for a Wide Range of Treatments for Small Peripheral Blood Vessels Including Ones Below The Knee
December 15, 2014

Corporate

Government of Ghana Endorses Collaboration to Combat Ebola Epidemic Page Content

AABB, Global Blood Fund and Terumo BCT commit resources to Ghanaian Ebola Readiness and Resilience Initiative
December 04, 2014

Corporate

Terumo receives CE Mark approval for the line extension on Drug-eluting Stent, Ultimaster® to advance the treatment of coronary artery disease
October 31, 2014

Corporate

Terumo Announces its Application for the Manufacture and Sales Approval of its Skeletal Myoblast Sheets - To Aim for the World's First Cardiac Regenerative Therapy (PDF 217.6 KB)
October 23, 2014

Corporate

Terumo transforms product portfolio of Hospital and Laboratory Business in Europe (PDF 177.35 KB)
September 23, 2014

Corporate

Terumo Cardiovascular Group to Distribute Nonin Medical’s SenSmart™ Model X-100 Universal Oximetry System in U.S. Cardiovascular Hospitals
August 08, 2014

Corporate

Announcement of a New Corporate Logo Mark
August 06, 2014

Financial

Notice Concerning the Issuance of Stock Option (Share Warrants) (PDF 56.35 KB)
May 20, 2014

Corporate

Terumo BCT Enters Agreement with Kaneka CorporationMulti-year collaboration agreement for the combined use of therapeutic apheresis and columns for LDL reduction
May 15, 2014

Corporate

Terumo® Launches Expanded GLIDEWAY™ Access Sheath Portfolio With A New Product For Minimally Invasive Urologic Procedures

New GLIDEWAY™ Ureteral Access Sheath Offers Advanced Features Designed to Minimize Trauma
May 08, 2014

Financial

Notice Concerning the Renewal of a Policy for Large-scale Acquisitions of Terumo Shares (Takeover Defense Measures) (PDF 129.84 KB)
April 24, 2014

Corporate

New Candidate for Independent Director
April 24, 2014

Corporate

Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant by U.S. Food & Drug Administration (FDA)
April 02, 2014

Corporate

Terumo Expands Sales Collaboration in Japan with Biosensors for Nobori® DES and Extends Licensing Agreement to Sell the Product Overseas
March 27, 2014

Corporate

Election of New Board Members
March 25, 2014

Corporate

Terumo BCT Becomes Therakos Inc. Distributor in Latin America

Multi-year agreement enables Terumo BCT to provide Therakos products in several Latin American countries
March 14, 2014

Corporate

Terumo Announces Exclusive Acquisition Right Agreement with French Bioresorbable Scaffold Company, "ART"
February 12, 2014

Corporate

Terumo Wins Pharmapack 2014 Award For Nanopass® 34 Pen-Needle In The Category "Quality Of Life"
February 03, 2014

Corporate

Terumo Receives CE Mark for Its New Drug-eluting Stent, Ultimaster™
January 28, 2014

Corporate

Nonin Medical Announces U.K. and Ireland Distribution Agreement with Terumo Cardiovascular Group in Europe for Nonin's SenSmart™ Universal Oximetry System
January 28, 2014

Corporate

U.S. Food and Drug Administration Clears Granulocyte Collection Procedure on the Spectra Optia Apheresis System

Granulocyte, or polymorphonuclear [PMN] cell, collections on the next-generation therapeutic apheresis platform to optimize cellular collections and supplement current protocol offering

Pagination

Previous page
Current page1
Next page

Footer Menu

Show — Footer Menu Hide — Footer Menu

- Investors
- News
  - - News
    - Press Inquiries
- Global Network

About Terumo
Business Overview
Sustainability
Technology
Investors
News
Global Network

Footer

Show — Footer Hide — Footer

Terms and Conditions of Use
Privacy Policy
Cookie Policy
Cookie Settings
Social Media Policy
Site Map

Copyright © 2022 Terumo Corporation, All Rights Reserved.